pAb/mAb to Human Neurological Disorders

mAb anti-Amyloid β Peptide 42, CA9 3B3

Catalogue #: MO-M40093A

Product Name Price Qty
mAb anti-Amyloid β Peptide 42, CA9 3B3, 0.1 mg
$200.00
mAb anti-Amyloid β Peptide 42, CA9 3B3, 0.5 mg
$320.00

Mouse monoclonal antibody to C-terminal of amyloid beta peptide 42 (Aβ42), Clone CA9 3B3

Description

Details

Description: Mouse monoclonal antibody to C-terminal of amyloid beta peptide 42 (Aβ42)

Purification: Protein G affinity purified

Target Protein: C-terminal of amyloid beta peptide 42

Immunogen: KLH conjugated to a short peptide (MVGGVVIA) with amino acid sequence corresponding to the C-terminal of Aβ42

Fusion Myeloma: Sp2/0-Ag14

Specificity: This antibody recognizes the C-terminal sequence (MVGGVVIA) of Aβ42 and full length Aβ42.

Cross-Reactivity: The antibody does not cross react with amyloid beta peptide 40 in dot blotting and ELISA. Cross-reactivity to amyloid beta peptide 43 is about 5% in ELISA.

Species Reacitvity: Human and other primates; mouse, rat

Host / Isotype: Mouse, IgG2b Kappa

Formulation: Lyophilized from a solution in 0.01M PBS pH7.2

Reconstitution: Double distilled water is recommended to adjust the final concentration to 1.00mg/mL. 

Storage: Store at -20oC

Research Area: Aging and neurodegenerative diseases

Background:  

Amyloid beta peptide 42 (Aβ42) is best known for its role in the formation of senile plaques in the brain of patients with Alzheimer’s disease. Aβ42 and Aβ40 are the two major amyloid peptides that are produced after cleavage of amyloid precursor protein by secretases. Aβ42 (42 amino acids) is very fibrillogenic. The beta pleated structure of Aβ42 constituents the initial and key component of the insoluble amyloid fibril in senile plaque. It is widely accepted that Aβ42 contributes to the pathogenesis of Alzheimer’s disease. One proposition is that the deposition of amyloid fibril onto the brain tissue results in Alzheimer’s disease. Another is that the neurotoxicity of Aβ42 oligomer is the cause of the disease.

Application: 

ELISA: In combination with capturer anti-amyloid peptide N-terminal antibody (mAb clone NT 4A2, Cat. No.: MO-M40094E), the antibody can detect Aβ42 in Sandwich ELISA assay.

Immuno-blot: Detect Aβ42 on dot blot using anti-Aβ42 clone CA9 3B3 (1μg/mL) on 10ng /dot of Aβ40 or Aβ42.

References:

If research is published using this product, please inform Anogen in order to cite the reference on this datasheet. Anogen will provide one unit of product in the same category as gratitude.

Additional

Additional Information

Product Specificity mAb anti-Amyloid β Peptide 42, CA9 3B3
Application EIA, WB
Size 0.1 mg
Contact Us